FMP
Profound Medical Corp.
PROF
NASDAQ
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
7.25 USD
-0.03 (-0.414%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Arun Swarup Menawat MBA, Ph.D.
sector
Healthcare
industry
Medical - Devices
exchange
NASDAQ
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
CIK
0001628808
ISIN
CA74319B5027
CUSIP
74319B502
Address
2400 Skymark Avenue
Phone
16474761350
Country
CA
Employee
131
IPO Date
Oct 29, 2019
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
PROF Financial Summary
CIK
0001628808
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
74319B502
ISIN
CA74319B5027
Country
CA
Price
7.25
Beta
0.83
Volume Avg.
65.93k
Market Cap
178.8M
Shares
-
52-Week
6.88-11.42
DCF
-6.93
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.41
P/B
-
Website
https://www.profoundmedical.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PROF News
It looks like there's no news available.
